HIGHLIGHTS
- who: Lufei Sui from the (median follow-up time of survivors, months have published the research work: PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression, in the Journal: (JOURNAL) of 11/06/2021
- what: The authors demonstrate that PRSS2 represses Tsp-1, not via its enzymatic activity, but by binding to low-density lipoprotein receptor-related protein 1 (LRP1). The authors demonstrate that treatment of WI38 cells with JNK inhibitor results in a 2.5-fold decrease in Tsp-1 expression in fibroblasts (1 vs 0.4, n . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.